Carlos Amaya-Chanaga

Carlos Amaya-Chanaga, MD, currently serves as the Senior Medical Director for Global Oncology Clinical Development at Bristol Myers Squibb, a position held since April 2024. Prior to this role, Carlos worked as Vice President of Clinical Development at Scorpion Therapeutics and as a Senior Clinical Trial Physician at Bristol Myers Squibb from May 2021 to May 2023. Carlos has extensive experience in oncology, including strategic roles in medical affairs at Eisai US and Pharmacyclics, both focusing on clinical development and research management. Carlos's academic background includes a Doctor of Medicine and Surgery from Universidad Industrial de Santander and ongoing PhD studies in Translational Health Sciences at The George Washington University, complemented by various specialized certifications from prestigious institutions such as Harvard Medical School and the University of Michigan.